The @McKinsey’s #biotech #investment themes article highlights “insufficient number of high-quality data”a limitation to AI #drugdiscovery #POLB‘s #AI programmes have access the world’s largest data & #biobank of high-dimensional #disease progression data
The @McKinsey’s #biotech #investment themes article highlights “insufficient number of high-quality data”a limitation to AI #drugdiscovery#POLB's #AI programmes have access the world's largest data & #biobank of high-dimensional #disease progression datahttps://t.co/E5rwZlIqu1
— Poolbeg Pharma (@PoolbegPharma) June 14, 2022